83616-0106 Tudriqev - CanMED: NDC

Product NDC:

83616-0106

Brand Name:

Tudriqev

Generic Name:

Vusolimogene oderparepvec-wtpg

Dosage Form Name:

INJECTION, SUSPENSION

Administration Route:

INTRATUMOR

Substances:

Name: VUSOLIMOGENE ODERPAREPVEC

Strength: 1000000.0

Unit: [PFU]/mL

Packages:

Code: 83616-0106-11

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (83616-106-11) / 1 mL in 1 VIAL, SINGLE-DOSE (83616-106-01)

Effective Date: Sept. 4, 2026

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Oncolytic Viral Therapy

Minor Class:

GALV-GP-R, GM-CSF

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox